AGRiMED develops environmentally-friendly, economically sustainable businesses in the communities in which we serve and our commitment to patient care is second to none. According to Healthline, 1 in every 26 people will be diagnosed with epilepsy, a neurological disorder caused by malfunctioning nerve cell activity in the brain. Epilepsy can affect people at any age from infants to elderly. Many wonder what could be the relief for their loved ones suffering from epilepsy. Evidence from laboratory studies, anecdotal reports, and small clinical studies suggest that medical cannabis can control seizures. Cannabis includes a compound called cannabidiol (CBD), one of at least 113 active cannabinoids identified in cannabis. It accounts for up to 40% of the plant’s extract and is the main ingredient for medical use. CBD is unlike the compound tetrahydrocannabinol (THC), the psychoactive component in cannabis that creates the euphoria. Experiments have shown that CBD has low binding to the CB1 and CB2 receptors of the brain that allow that experience, though it still has calming effects on the body. Unlike tetrahydrocannabinol (THC), which is responsible for its euphoric effects, CBD does not cause a “high” or cognitive alteration. Rather, research studies have shown that it can act as an anticonvulsant and may even have antipsychotic effects.
AGRIMED is an industry leader in developing cannabinoid-based medicines. AGRiMED has a commitment to finding CBD-based solutions to treat common, rare, and catastrophic forms of epilepsy. Studies to measure the effectiveness of products with a main ingredient of CBD showed about 45 percent of patients had a 50 percent or more reduction of seizures. Along with regular patients with just one seizure type, these studies and results also prove CBD’s positive effects on childhood-onset types and rare types of epilepsy such as Lennox Gastaut Syndrome (LGS). LGS is a less common combination of having more than one seizure type, a delay or loss of learning and learning skills, and a very specific age pattern.
More Benefits to be discovered in Medical Cannabis
Everything to know about medicine containing CBD has yet to be discovered due to much of the research still being ongoing and federal and state restrictions on the cannabis plant. AGRiMED is committed to expanding research in this area. Research on the helpfulness of CBD in seizures and other medical problems has been extremely positive and has helped to produce safe and effective products for patients.
Several medical cannabis companies lack the ability to confirm the specific strains they acquire to create and sell derivative products or sell as a whole plant, however, this is not the case for AGRiMED. With our team of expert biopharmaceutical scientists and geneticists, AGRiMED is developing advanced therapeutic cannabis strains to target patient specific medical needs. AGRiMED’s incredible natural products can and should one day help patients all over the world.
Holland, Kimberly. “Epilepsy by the Numbers: Facts, Statistics, and You.” Healthline. Healthline Media, 20 Oct. 2014. Web. 30 Apr. 2017.
Patel, Anup, MD. “Medical Marijuana and Epilepsy.” Epilepsy Foundation. Epilepsy Foundation, Mar. 2017. Web. 02 May 2017.